PR Newswire PharmaOriginal article
FMC Corporation reports second quarter 2026 results with Adjusted EBITDA above high end of guidance range and solid cash generation
EarningsNegative
AI Analysis
Summary
FMC Corporation reported Q2 2026 revenue of $867 million, down 17% year-over-year, with Adjusted EBITDA above guidance but updated full-year outlook due to challenging macroeconomic conditions.
Financial Highlights
Revenue
$867 million
Guidance
full-year outlook updated to reflect more challenging macro environment
Importance:4/10
Sentiment:
-0.30
earningsQ2 2026revenue declineguidance update
Read the original article
Published by PR Newswire Pharma on July 29, 2026 8:30 PM
